In today’s briefing:
- Viatris Inc: Initiation of Coverage – Recent Acquisitions & Other Drivers
- Viatris Inc: Detailed Credit Analysis & Financial Strength Evaluation Report
Viatris Inc: Initiation of Coverage – Recent Acquisitions & Other Drivers
- This is our first report on global healthcare giant, Viatris.
- The company had an interesting set of developments which included a strategic agreement to sell off their biosimilars business to Biocon Biologics.
- Due to the Famy Life Sciences acquisition, five more front-of-the-eye programs in diverse indications that are in Phase III or are ready for Phase III will be added.
Viatris Inc: Detailed Credit Analysis & Financial Strength Evaluation Report
- Viatris is a well-known global healthcare major with operations spread across North America, Europe, China, and other markets.
- The company’s financial performance has been in recovery mode and has been impacted by numerous industry headwinds, especially inflationary pressures.
- It had an interesting set of developments which included a strategic agreement to sell off their biosimilars business to Biocon Biologics.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
